Large Cap Archives - Page 124 of 437

2 minute read

Wall Street Slips As Rate-Cut Hopes Diminish With Inflation, Bitcoin Remains Unmoved By ETF Debut: What’s Driving Markets Thursday?

January 11, 3:10 PM

It’s a bearish Thursday on Wall Street, with stocks relinquishing their gains due to unexpectedly high inflation numbers for December, causing some turbulence in market expectations regarding earlier Federal Reserve rate cuts.<

AAPL

3 minute read

Bank Earnings Season Begins Friday: Analysts Warn Of Possible ‘Sell-Off’ On Day 1

By Piero Cingari

January 11, 2:37 PM

6 banks are scheduled to unveil their fourth-quarter results Friday. Will there be a sell-off?

BAC

2 minute read

Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo and Lilly’s Dominance

By Vandana Singh

January 11, 12:40 PM

Pharmaceutical companies, including Amgen Inc (NASDAQ: AMGN) and Pfizer Inc (NYSE: PFE), are strategically positioning themselves to tap into the

ALT

1 minute read

SAP’s ~$220M Cleanup: German Software Giant Settles Foreign Bribery Charges

By Lekha Gupta

January 11, 11:13 AM

SAP SE (NYSE: SAP) has agreed to pay over

SAP

2 minute read

AbbVie’s Strategic Move: ImmunoGen Acquisition Triggers Golden Cross, Yet Valuation Caution Remains

By Surbhi Jain

January 11, 11:01 AM

AbbVie Inc (ABBV) stock is up 15% since acquiring ImmunoGen, but past Golden Cross rallies haven't sustained. With high valuation and competition, investors may want to wait for a pullback.

ABBV

2 minute read

Why Southwestern Energy Shares Are Down Today

By Lekha Gupta

January 11, 10:40 AM

Southwestern Energy Co (NYSE: SWN) shares are trading lower after it announced a merger deal with Chesapeake Energy Corp (NASDAQ: CHK).

CHK

2 minute read

FDA Allows Importing Unapproved But Essential Syphilis Treatment Amid Shortage Of Pfizer’s Antibiotic

By Vandana Singh

January 11, 10:24 AM

FDA collaborates with Laboratoires Delbert to address syphilis treatment shortage. Learn about the temporary import of Extencilline, an alternative to Bicillin. Shortage expected until June.

PFE

2 minute read

Marc Chaikin’s Buy The Dip Stock Pick Just Made A Golden Cross

By Surbhi Jain

January 11, 10:14 AM

The founder and CEO of Chaikin Analytics pointed to 3M's stock, which didn't have the best year but there's a lot of upside.

MMM

2 minute read

Aesthetics Market Resilience: AbbVie Asserts Widely Used Botox Dominance Amidst Rising Competition

By Vandana Singh

January 11, 9:31 AM

AbbVie Inc's (NYSE: ABBV) unwavering confidence in Botox's resilience within the aesthetics market with a commanding 68% market share remains steadfast. Despite a recent FDA petition addressing potential risks, AbbVie emphasizes its commitment to safety with existing 'black box' warnings. Amidst economic uncertainties and emerging competitors, AbbVie anticipates continued strength.

ABBV

1 minute read

Citigroup Reveals Billions Of Charges In Q4 Ahead Of Earnings

By Lekha Gupta

January 11, 9:13 AM

Citi will release fourth quarter and full-year 2023 earnings on January 12, 2024.